
XVIVO Perfusion Investor Relations Material
Latest events

Q1 2025
XVIVO Perfusion
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from XVIVO Perfusion
Access all reports
Xvivo Perfusion AB, a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation. The company's primary product line are the xVivo Perflex System and the xVivo S System that combine perfusion technology with a robust cryopreservation solution to maintain viability of cells outside the body. The xVivo Perflex System is used for functional organ preservation. The company is based in Gothenburg, Sweden.
Key slides for XVIVO Perfusion


Q1 2025
XVIVO Perfusion


Q4 2024
XVIVO Perfusion
Latest articles
)
Ron Vachris: From Forklift Driver to CEO at Costco
Ron Vachris took over as Costco CEO in 2024, following a 40-year journey from warehouse floors to the top of one of retail's most admired companies.
18 Jun 2025
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
Ticker symbol
XVIVO
Country
🇸🇪 Sweden